Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Public ClinicalTrials.gov record NCT05126901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Open-label, Active-controlled, Multicentre, Comparative Study to Evaluate the Safety and Efficacy of Ferric Maltol (Iron (III)-Maltol Complex) (ST10) Oral Suspension Compared to Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, Incorporating a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Study identification
- NCT ID
- NCT05126901
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Shield Therapeutics
- Industry
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- Ferric Maltol Drug
- Ferrous sulfate Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Month to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2, 2021
- Primary completion
- Jun 8, 2024
- Completion
- Jun 8, 2024
- Last update posted
- Nov 9, 2025
2021 – 2024
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Center for Clinical Trials | Saraland | Alabama | 36571 | — |
| Homestead Research Institute | Homestead | Florida | 33030 | — |
| Kissimmee Clinical Research Corp | Kissimmee | Florida | 34743 | — |
| Miami Clinical Research | Miami | Florida | 33155 | — |
| Medical Research of Westcheste | Miami | Florida | 33165 | — |
| Eminent Clinical Research and Associates | North Lauderdale | Florida | 33068 | — |
| Clinical Research Prime | Idaho Falls | Idaho | 83404 | — |
| Sierra Clinical Research | Las Vegas | Nevada | 89106 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| Penn State Hershey Children's Hospital | Hershey | Pennsylvania | 17033 | — |
| Hasbro Children's Hospital | Providence | Rhode Island | 02903 | — |
| BRCR Global Texas | Edinburg | Texas | 78539 | — |
| Zion Research | Katy | Texas | 77494 | — |
| MultiCare Health System Institute for Research and Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05126901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05126901 live on ClinicalTrials.gov.